Healthcare -
Biotechnology - NASDAQ - US
$ 0.861
-1.77 %
$ 35.7 M
Market Cap
-0.55
P/E
RLYB - COST OF REVENUE
Cost of Revenue RLYB - Rallybio Corporation
150 K
LAST VALUE
17.31%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR